Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto-Kakizaki rats.

Simonsen, L; Pilgaard, S; Orskov, C; Hartmann, B; Holst, J J; Deacon, C F

Simonsen, L; Pilgaard, S; Orskov, C; Hartmann, B; Holst, J J; Deacon, C F.

Affiliation

Simonsen L; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Diabetes Obes Metab ; 11(9): 884-90, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19508463

Subject(s)

Hypoglycemic Agents/therapeutic use; Peptides/therapeutic use; Receptors, Glucagon/antagonists & inhibitors; Venoms/therapeutic use; Animals; Area Under Curve; Blood Glucose/analysis; Blood Glucose/metabolism; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/physiopathology; Disease Models, Animal; Exenatide; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin/metabolism; Insulin/blood; Pancreas/pathology; Rats; Rats, Mutant Strains; Rats, Wistar

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Venoms / Receptors, Glucagon / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2009 Document type: Article Affiliation country: Denmark Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google